Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

Introduction

This page provides a comprehensive analysis of the known insider trading history of Charles J Dockendorff. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Charles J Dockendorff has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HAE / Haemonetics Corporation Director 7,126
US:KEYS / Keysight Technologies, Inc. Director 54,343
US:HOLX / Hologic, Inc. Director 3,436
US:BSX / Boston Scientific Corporation Director 2,901
US:COV / EVP & Chief Financial Officer 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Charles J Dockendorff. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases HAE / Haemonetics Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HAE / Haemonetics Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HAE / Haemonetics Corporation Insider Trades
Insider Sales HAE / Haemonetics Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HAE / Haemonetics Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-02-04 HAE Dockendorff Charles J 12,180 134.5300 12,180 134.5300 1,638,575 357 43.7700 -1,105,456 -67.46

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HAE / Haemonetics Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Charles J Dockendorff as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-25 2025-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,693 7,126 60.75
2025-03-25 2025-03-21 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,589 54,343 3.01
2025-02-28 2025-02-26 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,864 3,436 118.58
2024-07-26 2024-07-25 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,207 4,433 99.15
2024-05-13 2024-05-09 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 2,901 2,901
2024-05-08 2024-05-07 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
S - Sale X -3,946 0 -100.00 72.70 -286,874
2024-03-26 2024-03-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,632 52,754 3.19
2024-03-11 2024-03-08 4 HOLX HOLOGIC INC
Common Stock
S - Sale X -1,465 1,572 -48.24 76.21 -111,648 119,802
2024-03-11 2024-03-07 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,572 3,037 107.30
2024-01-04 2024-01-02 4 HOLX HOLOGIC INC
Common Stock
S - Sale X -16,017 1,465 -91.62 72.00 -1,153,224 105,480
2024-01-04 2024-01-02 4 HOLX HOLOGIC INC
Common Stock
M - Exercise X 7,551 17,482 76.03 38.44 290,260 672,008
2023-09-07 2023-09-05 4 HAE HAEMONETICS CORP
Common Stock
S - Sale X -10,215 2,226 -82.11 87.68 -895,651 195,176
2023-08-18 2023-08-18 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
S - Sale X -17,079 3,946 -81.23 50.74 -866,631 200,230
2023-08-08 2023-08-04 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,226 12,441 21.79
2023-05-05 2023-05-04 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 3,946 21,025 23.10
2023-05-05 2023-01-06 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
G - Gift -8,201 0 -100.00
2023-03-21 2023-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,543 51,122 3.11
2023-03-13 2023-03-09 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,465 6,725 27.85
2023-02-09 2023-02-07 4 HOLX HOLOGIC INC
Common Stock
G - Gift -1,336 0 -100.00
2023-01-10 2023-01-06 4 KEYS Keysight Technologies, Inc.
Common Stock
G - Gift -2,844 0 -100.00
2022-12-14 2022-12-13 4 KEYS Keysight Technologies, Inc.
Common Stock
S - Sale -3,257 52,423 -5.85 185.06 -602,753 9,701,682
2022-12-14 2022-12-12 4 KEYS Keysight Technologies, Inc.
Common Stock
G - Gift -7,551 55,680 -11.94
2022-08-08 2022-08-05 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,730 28,130 10.75
2022-05-09 2022-05-05 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 4,877 17,079 39.97
2022-03-22 2022-03-18 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,626 63,231 2.64
2022-03-14 2022-03-10 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 5,293 5,293
2022-03-14 2022-03-10 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,565 5,260 42.35
2021-12-07 2021-03-31 5 KEYS Keysight Technologies, Inc.
Common Stock
G - Gift -3,240 0 -100.00
2021-08-09 2021-08-06 4 HAE HAEMONETICS CORP
Common Stock
A - Award 3,077 25,400 13.78
2021-05-10 2021-05-06 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 2,439 39,501 6.58
2021-05-10 2021-05-06 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 4,763 37,062 14.75
2021-03-23 2021-03-19 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,631 64,845 2.58
2021-03-15 2021-03-11 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 5,055 5,055
2021-03-15 2021-03-11 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,478 3,695 66.67
2021-02-05 2021-02-04 4 HAE HAEMONETICS CORP
Non-qualified Stock Option (Right to Buy)
M - Exercise -12,180 0 -100.00
2021-02-05 2021-02-04 4 HAE HAEMONETICS CORP
Common Stock
S - Sale -12,180 13,755 -46.96 134.53 -1,638,575 1,850,460
2021-02-05 2021-02-04 4 HAE HAEMONETICS CORP
Common Stock
M - Exercise 12,180 25,935 88.55 35.50 432,420 920,757
2020-07-22 2020-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,983 13,755 16.85
2020-05-11 2020-05-07 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 5,000 16,099 45.05
2020-03-23 2020-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,438 63,214 4.01
2020-03-09 2020-03-05 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 7,322 7,322
2020-03-09 2020-03-05 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,217 22,129 11.13
2019-07-26 2019-07-24 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,460 20,340 7.73
2019-05-13 2019-05-09 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 4,990 11,099 81.68
2019-03-25 2019-03-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,351 60,776 4.02
2019-03-11 2019-03-07 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 6,523 6,523
2019-03-11 2019-03-07 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,136 19,912 12.02
2018-07-30 2018-07-26 4 HAE HAEMONETICS CORP
Common Stock
A - Award 1,696 18,880 9.87
2018-05-11 2018-05-10 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 6,109 63,213 10.70
2018-03-26 2018-03-23 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 3,897 58,425 7.15
2018-03-26 2018-03-23 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 780 54,528 1.45
2018-03-26 2018-03-23 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,949 53,749 3.76
2018-03-16 2018-03-15 4 HOLX HOLOGIC INC
Common Stock
P - Purchase 13,000 17,776 272.19 38.80 504,400 689,709
2018-03-16 2018-03-14 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 7,551 7,551
2018-03-16 2018-03-14 4 HOLX HOLOGIC INC
Common Stock
A - Award 2,406 4,776 101.52
2017-07-31 2017-07-27 4 HAE HAEMONETICS CORP
Common Stock
A - Award 4,329 17,184 33.68 39.27 170,000 674,816
2017-06-13 2017-06-09 4 KEYS Keysight Technologies, Inc.
Common Stock
P - Purchase 13,210 51,800 34.23 37.81 499,470 1,958,554
2017-05-16 2017-05-15 4 HOLX HOLOGIC INC
Non-qualified Stock Option (Right to Buy)
A - Award 5,396 5,396
2017-05-16 2017-05-15 4 HOLX HOLOGIC INC
Common Stock
A - Award 1,747 2,370 280.42
2017-05-16 3 HOLX HOLOGIC INC
Common Stock
1,246
2017-05-16 3 HOLX HOLOGIC INC
Common Stock
1,246
2017-05-11 2017-05-09 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 7,012 57,104 14.00
2017-03-20 2017-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 4,720 38,590 13.94 39.02 184,174 1,505,778
2017-03-20 2017-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 656 33,870 1.97 39.02 25,584 1,321,604
2017-03-20 2017-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,360 33,214 7.65 39.02 92,101 1,296,020
2016-05-04 2016-05-03 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 8,494 50,092 20.42
2016-03-21 2016-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 962 30,844 3.22 25.98 25,000 801,325
2016-03-21 2016-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 3,464 29,882 13.11 25.98 90,000 776,325
2016-03-21 2016-03-17 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 6,928 26,417 35.55 25.98 179,989 686,325
2016-02-16 2016-02-12 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
P - Purchase 30,000 41,598 258.67 16.49 494,688 685,934
2015-11-09 2015-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 656 19,489 3.48 38.74 25,405 755,020
2015-11-09 2015-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 2,397 18,834 14.58 38.74 92,852 729,615
2015-11-09 2015-01-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,122 16,437 7.33 35.78 40,140 588,110
2015-07-23 2015-07-21 4 HAE HAEMONETICS CORP
Common Stock
A - Award 4,337 7,153 154.01
2015-05-07 2015-05-05 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 10,650 11,598 1,123.42
2015-05-04 2015-05-01 4 BSX BOSTON SCIENTIFIC CORP
Common Stock
A - Award 948 948
2015-03-23 2015-03-20 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 4,793 15,315 45.55
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -78,769 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -65,095 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -103,051 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -132,583 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Stock Option (Right to Buy)
D - Sale to Issuer -107,632 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -88,753 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -107,179 0 -100.00
2015-01-28 2015-01-26 4 COV Covidien plc
Ordinary Shares
D - Sale to Issuer -3,776 107,179 -3.40
2015-01-26 2015-01-22 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 1,756 10,522 20.03
2014-12-04 2014-12-03 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,061 47,278 -2.19 102.36 -108,604 4,839,376
2014-12-03 2014-12-02 4 COV Covidien plc
Ordinary Shares
F - Taxes -812 48,339 -1.65 101.61 -82,507 4,911,726
2014-12-03 2014-12-01 4 COV Covidien plc
Ordinary Shares
F - Taxes -3,342 49,151 -6.37 100.99 -337,509 4,963,759
2014-12-03 2014-12-01 4 COV Covidien plc
Ordinary Shares
A - Award 3,763 52,493 7.72
2014-11-07 2014-11-05 4 KEYS Keysight Technologies, Inc.
Common Stock
A - Award 8,766 8,766
2014-10-07 2014-10-03 4 COV Covidien plc
Ordinary Shares
F - Taxes -22,418 48,638 -31.55 93.89 -2,104,826 4,566,622
2014-10-07 2014-10-03 4 COV Covidien plc
Ordinary Shares
A - Award 47,490 71,056 201.52
2014-07-25 2014-07-23 4 HAE HAEMONETICS CORP
Non-Qualified Stock Option (right to buy)
A - Award 12,180 12,180
2014-07-25 2014-07-23 4 HAE HAEMONETICS CORP
Common Stock
A - Award 2,816 2,816
2014-07-25 3 HAE HAEMONETICS CORP
Common Stock
5,632
2014-07-25 3 HAE HAEMONETICS CORP
Common Stock
5,632
2014-03-28 2014-03-28 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -90,730 0 -100.00
2014-03-28 2014-03-28 4 COV Covidien plc
Ordinary Shares
S - Sale X -90,730 112,131 -44.73 72.50 -6,577,925 8,129,498
2014-03-28 2014-03-28 4 COV Covidien plc
Ordinary Shares
M - Exercise 90,730 202,861 80.91 39.32 3,567,504 7,976,495
2014-02-24 2014-02-20 4 COV Covidien plc
Ordinary Shares
A - Award 104 112,131 0.09 71.28 7,413 7,992,698
2014-01-10 2014-01-10 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -90,000 90,730 -49.80
2014-01-10 2014-01-10 4 COV Covidien plc
Ordinary Shares
S - Sale X -90,000 112,027 -44.55 69.50 -6,255,000 7,785,876
2014-01-10 2014-01-10 4 COV Covidien plc
Ordinary Shares
M - Exercise 90,000 202,027 80.34 39.32 3,538,800 7,943,702
2013-12-12 2013-12-02 4/A COV Covidien plc
Ordinary Shares
A - Award 6,757 113,071 6.36
2013-12-04 2013-12-03 4 COV Covidien plc
Ordinary Shares
F - Taxes -1,044 170,365 -0.61 67.24 -70,199 11,455,343
2013-12-04 2013-12-02 4 COV Covidien plc
Stock Option (Right to Buy)
A - Award 6,757 6,757
2013-12-04 2013-12-02 4 COV Covidien plc
Ordinary Shares
A - Award 65,095 171,409 61.23
2013-12-04 2013-12-01 4 COV Covidien plc
Ordinary Shares
F - Taxes -4,959 106,314 -4.46 68.26 -338,501 7,256,994
2013-11-15 2013-11-15 4 COV Covidien plc
Ordinary Shares
S - Sale -39,397 111,273 -26.15 66.22 -2,609,023 7,368,932
2013-11-07 2013-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 146 150,670 0.10 64.33 9,392 9,692,601
2013-09-30 2013-09-27 4 COV Covidien plc
Ordinary Shares
F - Taxes -15,144 150,524 -9.14 60.96 -923,178 9,175,943
2013-09-30 2013-09-27 4 COV Covidien plc
Ordinary Shares
A - Award 32,080 165,668 24.01
2013-08-16 2013-08-15 4 COV Covidien plc
Ordinary Shares
A - Award 119 133,588 0.09 61.85 7,360 8,262,418
2013-08-16 2012-12-21 4 COV Covidien plc
Ordinary Shares
G - Gift -4,350 131,103 -3.21
2013-08-08 2013-08-08 4 COV Covidien plc
Ordinary Shares
S - Sale -391 137,819 -0.28 63.71 -24,911 8,780,448
2013-08-08 2013-08-07 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -31,816 0 -100.00
2013-08-08 2013-08-07 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -27,409 0 -100.00
2013-08-08 2013-08-07 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -35,572 0 -100.00
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
S - Sale -94,797 138,210 -40.68 63.15 -5,986,269 8,727,727
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
M - Exercise 27,409 233,007 13.33 33.76 925,328 7,866,316
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
M - Exercise 31,816 205,598 18.31 31.16 991,387 6,406,434
2013-08-08 2013-08-07 4 COV Covidien plc
Ordinary Shares
M - Exercise 35,572 173,782 25.74 41.66 1,481,930 7,239,758
2013-05-07 2013-05-03 4 COV Covidien plc
Ordinary Shares
A - Award 105 135,677 0.08 64.35 6,757 8,730,815
2013-02-12 2013-02-11 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -32,457 0 -100.00
2013-02-12 2013-02-11 4 COV Covidien plc
Ordinary Shares
S - Sale -32,457 135,572 -19.32 63.31 -2,054,905 8,583,280
2013-02-12 2013-02-11 4 COV Covidien plc
Ordinary Shares
M - Exercise 32,457 168,029 23.94 35.45 1,150,708 5,957,183
2012-12-28 2012-12-27 4 COV Covidien plc
Ordinary Shares
A - Award 119 135,572 0.09 57.35 6,825 7,775,054
2012-12-04 2012-12-03 4 COV Covidien plc
Stock Option (Right to Buy)
A - Award 71,870 71,870
2012-12-04 2012-12-03 4 COV Covidien plc
Ordinary Shares
A - Award 7,921 135,453 6.21
2012-12-04 2012-12-01 4 COV Covidien plc
Ordinary Shares
F - Taxes -5,818 127,532 -4.36 58.11 -338,084 7,410,885
2012-11-26 2012-11-23 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -87,090 29,030 -75.00
2012-11-26 2012-11-23 4 COV Covidien plc
Stock Option (Right to Buy)
M - Exercise -47,039 0 -100.00
2012-11-26 2012-11-23 4 COV Covidien plc
Ordinary Shares
S - Sale -134,129 133,350 -50.15 57.00 -7,645,353 7,600,950
2012-11-26 2012-11-23 4 COV Covidien plc
Ordinary Shares
M - Exercise 47,039 267,479 21.34 38.65 1,817,987 10,337,662
2012-11-26 2012-11-23 4 COV Covidien plc
Ordinary Shares
M - Exercise 87,090 220,440 65.31 34.15 2,974,124 7,528,026
2012-11-07 2012-11-05 4 COV Covidien plc
Ordinary Shares
A - Award 148 133,350 0.11 55.65 8,236 7,420,928
2012-10-09 2012-10-04 4 COV Covidien plc
Ordinary Shares
F - Taxes -10,564 133,202 -7.35 60.16 -635,530 8,013,432
2012-10-09 2012-10-04 4 COV Covidien plc
Ordinary Shares
A - Award 25,300 143,766 21.36
2012-08-20 2012-08-16 4 COV Covidien plc
Ordinary Shares
A - Award 126 118,466 0.11 57.59 7,256 6,822,457
2012-05-09 2012-05-07 4 COV Covidien plc
Ordinary Shares
A - Award 131 118,340 0.11 54.25 7,107 6,419,945
2012-02-24 2012-02-22 4 COV Covidien plc
Ordinary Shares
A - Award 136 118,209 0.12 52.45 7,133 6,200,062
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)